Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Misoprostol Dose Comparison for Cervical Ripening Prior to Hysteroscopy
NCT04152317Phase 3Completed
- Sponsor
- IMIP
- Start
- Nov 2019
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of misoprostol in uterine cavity disorders and Cervical canal disorder (2 arms), sponsored by IMIP. Primary endpoint: Cervical canal width. Started Nov 2019; status: completed.
02
Drugs
misoprostol
03
Conditions
uterine cavity disordersCervical canal disorder
Beyond the preview
Go deeper on NCT04152317.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04152317.